Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No exemption for medical devices or IVDs (in vitro diagnostics) in EU's REACH, as Parliament and Council strike informal deal

This article was originally published in Clinica

Executive Summary

There is to be no escape for the medtech industry, and particularly the in vitro diagnostics industry, it seems, from new restrictions on the materials that they can use in manufacture and processing of their products as a result of the latest developments on the EU's REACH chemicals safety bill. The European Parliament and the Council have worked out an informal deal on the text, with little to now derail it. And medical devices and diagnostics are included within its scope.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel